Limitations of Prostate-specific Antigen Testing After a Prostate Cancer Diagnosis.

Journal Article (Editorial)

Prostate-specific antigen (PSA) is frequently used in isolation to guide treatment decisions in men with recurrent prostate cancer, a practice discouraged by prostate cancer working groups and guidelines. Instead, PSA should be used with imaging and other factors to make treatment decisions.

Full Text

Duke Authors

Cited Authors

  • Caram, MEV; Skolarus, TA; Cooney, KA

Published Date

  • August 2016

Published In

Volume / Issue

  • 70 / 2

Start / End Page

  • 209 - 210

PubMed ID

  • 26776937

Electronic International Standard Serial Number (EISSN)

  • 1873-7560

Digital Object Identifier (DOI)

  • 10.1016/j.eururo.2015.12.045


  • eng

Conference Location

  • Switzerland